Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Avantor, Inc. (AVTR : NYSE)
 
 • Company Description   
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.

Number of Employees: 13,500

 
 • Price / Volume Information   
Yesterday's Closing Price: $9.27 Daily Weekly Monthly
20 Day Moving Average: 15,072,995 shares
Shares Outstanding: 682.06 (millions)
Market Capitalization: $6,322.66 (millions)
Beta: 0.94
52 Week High: $18.02
52 Week Low: $8.90
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -24.08% -24.14%
12 Week -21.04% -21.83%
Year To Date -19.11% -19.53%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
BUILDING ONE SUITE 200 100 MATSONFORD ROAD
-
RADNOR,PA 19087
USA		 ph: 610-386-1700
fax: -		 avantorir@avantorsciences.com http://www.avantorsciences.com
 
 • General Corporate Information   
Officers
Emmanuel Ligner - President and Chief Executive Officer
Greg Summe - Chairman of the Board of Directors
R. Brent Jones - Executive Vice President and Chief Financial Offic
Steven Eck - Senior Vice President and Chief Accounting Officer
Juan Andres - Director

Peer Information
Avantor, Inc. (CHCR)
Avantor, Inc. (ESRX)
Avantor, Inc. (MYDP)
Avantor, Inc. (COR)
Avantor, Inc. (GBCS)
Avantor, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 05352A100
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 04/24/26
Share - Related Items
Shares Outstanding: 682.06
Most Recent Split Date: (:1)
Beta: 0.94
Market Capitalization: $6,322.66 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.16 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.79 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 3.23% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 04/24/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 11.79
Trailing 12 Months: 10.19
PEG Ratio: 3.65
Price Ratios
Price/Book: 1.14
Price/Cash Flow: 6.12
Price / Sales: 0.96
EPS Growth
vs. Year Ago Period: -18.52%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: -1.36%
vs. Previous Quarter: 2.45%
ROE
12/31/25 - 10.45
09/30/25 - 10.91
06/30/25 - 11.39
ROA
12/31/25 - 5.06
09/30/25 - 5.34
06/30/25 - 5.44
Current Ratio
12/31/25 - 1.78
09/30/25 - 1.49
06/30/25 - 0.98
Quick Ratio
12/31/25 - 1.18
09/30/25 - 0.96
06/30/25 - 0.67
Operating Margin
12/31/25 - 9.38
09/30/25 - 9.92
06/30/25 - 10.21
Net Margin
12/31/25 - -8.09
09/30/25 - -1.25
06/30/25 - 10.31
Pre-Tax Margin
12/31/25 - -6.74
09/30/25 - 0.94
06/30/25 - 12.39
Book Value
12/31/25 - 8.16
09/30/25 - 8.17
06/30/25 - 9.22
Inventory Turnover
12/31/25 - 5.61
09/30/25 - 5.75
06/30/25 - 5.85
Debt-to-Equity
12/31/25 - 0.70
09/30/25 - 0.65
06/30/25 - 0.48
Debt-to-Capital
12/31/25 - 41.30
09/30/25 - 39.51
06/30/25 - 32.22
 

Powered by Zacks Investment Research ©